Dementia experts hail “watershed moment” after trial results for donanemab antibody treatment.

  • dedale@kbin.social
    link
    fedilink
    arrow-up
    12
    ·
    edit-2
    1 year ago

    Very skeptical of that one.
    They’ve been trying to target amyloid for more than a decade, and it’s the first time I hear of it actually working.

    The treatment seem to have huge side effects (brain bleeding and swelling) and lead to patient death during the study.
    Elly Lilly is also know for marketing zyprexa as a treatment for dementia (despite inefficacy and increased risk of death). Which is IMO criminal, at best unethical. I’m not inclined to trust them at all.

    I hope I’m wrong and it works. Alzheimer is a terrible way to go.